Update README.md

README.md

@@ -50,14 +50,15 @@ CancerVerse is continuously evolving. We are releasing it in stages so the commu
 
 ### ✅ Available now
 
-- **De-identified CT volumes** — 24,168 3D scans from 13,863 patients, across multiple scanners and **4 contrast phases**.
-- **Paired radiology reports** — the radiologist's full free-text impression for 24,168 scans. Real clinical language, ready for report generation, information extraction, and image–text pre-training.
+- **De-identified CT volumes** — 22,865 3D scans from 13,863 patients, across multiple scanners and **4 contrast phases**.
+- **Paired radiology reports** — the radiologist's full free-text impression for 22,865 scans. Real clinical language, ready for report generation, information extraction, and image–text pre-training.
 - **Scan-level context** — sex, age, exam date, contrast phase, scanner, and study/series/protocol descriptions for every volume.
 - **Longitudinal linkage** — stable de-identified patient IDs + exam dates let you reconstruct each patient's imaging timeline (up to **26 timepoints**, spanning up to **14.4 years**).
 
 ### 🔜 Coming soon
 
-- 🧬 **Structured tumor features** *(by August 2026)* — per-organ malignancy status, largest-lesion **diameters, locations, attenuation**, and **tumor staging**.
+- 🧬 **Remaining CT volumes and reports** *(by August 2026)* — the rest of the full **24,168-volume** cohort, added as de-identification completes.
+- 📊 **Structured tumor features** *(by August 2026)* — per-organ malignancy status, largest-lesion **diameters, locations, attenuation**, and **tumor staging**.
 - 🔬 **Pathology results** *(by August 2026)* — ICD-10 codes.
 - 🎯 **Expert manual segmentation annotations** *(by September 2026)* — voxel-level, radiologist-verified **tumor** annotations.
 - 📋 **Clinical & longitudinal layer** *(by September 2026)* — cancer histology, TNM stage, treatments received, surgical resections, **RECIST treatment response**, metastatic sites, disease-status narratives, follow-up recommendations, comorbidities, and devices/implants.